Article
Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics
17 Jun 2022
Abstract excerpt
The prevalence of metabolic diseases, including obesity, dyslipidemia, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD), is a severe burden in human society owing to the ensuing high morbidity and mortality. Various factors linked to metabolic disorders, particularly environmental factors (such as diet and gut microbiota) and epigenetic modifications, contribute to the progression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
